FDA tranexamic acid coverage for business development, investment, and market access teams
The FDA has approved RapidClot, a tranexamic acid formulation, to effectively manage trauma bleeding, providing critical support in emergency medical care.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
